ondasdechoque.org
PT-BR

Focused shockwaves as a diagnostic stimulus in low-back pain · Single-group study · 2024

Can focused shockwave help pinpoint painful muscle spots in low back pain?

In this study of 28 adults with long-lasting low back pain, focused shockwave was aimed at muscle spots first found by touch. It very often made pain spread and usually brought on people's familiar pain, for example in 22 of 26 deep lower-back muscle spots. Treatment itself was not tested.

Explores shockwave for finding pain spots
adults with long-lasting low back pain
28
muscle spots tested
115
of 28 people had pain spread or felt familiar pain
27

Good to know: 28 people at one centre; each person could have several spots tested.

Müller-Ehrenberg H, Giordani F, Müller-Ehrenberg A, et al. Biomedicines, 2024 · Read the paper ↗

How this study worked

StartFollow-up28 people
One group was followed over time, without a comparison group. Each dot is one person.

Conceptual animation: a focused front converges, then spreads. Not to scale. Tap the field to send a pulse.

The treatment

Focused shockwave test

Focused

Focused wavesMeet at a focal zone below the skin
Strength
0.06–0.30mJ/mm² (adjusted to what each person could tolerate) · 5 per second
Numbing
Not mentioned
Device
Wolf PiezoWave2 FB10 G10

Compared with: No comparison group; shockwave was used as a test, not a treatment

Settings are what each study used, not a prescription.

Who took part

28 adults (15 women, 13 men; average age 59) with long-lasting low back pain of no clear cause, recruited through a newspaper advertisement.

Focused shockwave test28 people

Side effects

Testing was meant to bring on pain, kept within what each person could tolerate. The paper gives no side-effect counts.

All the numbers and the full appraisal

Every reported result

FROM THE FULL PAPER

The results, in numbers.

Twenty-eight adults with chronic nonspecific low-back pain were recruited by newspaper advertisement: 15 women, 13 men, mean age 59.0 years and mean symptom duration 87.39 months. Investigators selected 115 trigger-point/muscle observations; these are not 115 independent patients.

Diagnostic cohort28enrolled

Participants; no attrition reported.

Pain referral1 reported outcome
01
During diagnostic stimulation

Pain referral

Pain referral Selected muscle/trigger-point observations

Observed subgroup counts; these are not randomized treatment arms.

Quadratus lumborum25 / 26
Gluteus medius22 / 23
Gluteus minimus13 / 14
Iliopsoas13 / 14
Erector spinae6 / 7
Biceps femoris5 / 6
Piriformis9 / 11
Adductors9 / 14

Referral occurred in 25/26 quadratus-lumborum, 22/23 gluteus-medius and 13/14 gluteus-minimus selections; recognition in 22/26, 20/23 and 12/14. Iliopsoas referral was 13/14 but recognition only 7/14. One of 28 participants had neither response. These are elicitation proportions, not sensitivity, specificity or validated diagnostic accuracy.

Analysis details and source

Muscle/site selections overlap within 28 people; bilateral responses separately recorded. Table headings say patients but text says 115 MTrPs. Counts are not independent people or diagnostic sensitivity.

Familiar pain recognition1 reported outcome
02
During diagnostic stimulation

Familiar pain recognition

Familiar pain recognition Selected muscle/trigger-point observations

Observed subgroup counts; these are not randomized treatment arms.

Quadratus lumborum22 / 26
Gluteus medius20 / 23
Gluteus minimus12 / 14
Iliopsoas7 / 14
Erector spinae5 / 7
Biceps femoris2 / 6
Piriformis4 / 11
Adductors4 / 14

Referral occurred in 25/26 quadratus-lumborum, 22/23 gluteus-medius and 13/14 gluteus-minimus selections; recognition in 22/26, 20/23 and 12/14. Iliopsoas referral was 13/14 but recognition only 7/14. One of 28 participants had neither response. These are elicitation proportions, not sensitivity, specificity or validated diagnostic accuracy.

Analysis details and source

Muscle/site selections overlap within 28 people; bilateral responses separately recorded. Table headings say patients but text says 115 MTrPs. Counts are not independent people or diagnostic sensitivity.

How treatment was delivered
Diagnostic stimulation

Wolf PiezoWave2 FB10 G10 focused source, approximately 10-mm focal zone, 5 Hz and 0.06–0.30 mJ/mm² adjusted to verbal tolerance. Gel spacers placed the focus 3–5 cm deep for lumbar/gluteal targets or 1–3 cm for superficial targets. Total pulses per diagnostic point were not reported.

HARMS & TOLERABILITY

Pain was intentionally elicited and intensity adjusted to tolerance. No systematic adverse-event counts are provided. No external funding or conflicts were declared.

LIMITS OF THE ANALYSIS

The authors acknowledge one centre/investigator and palpation preselection. Small selected sample, subjective responses, no blinding or reference standard, repeated sites within participants and ambiguous units prevent claims of diagnostic accuracy or reproducibility. The reported recruitment end date is 31 September 2022, an invalid calendar date.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • The authors acknowledge one centre/investigator and palpation preselection. Small selected sample, subjective responses, no blinding or reference standard, repeated sites within participants and ambiguous units prevent claims of diagnostic accuracy or reproducibility. The reported recruitment end date is 31 September 2022, an invalid calendar date.
Research review

Source-linked critical reading

Single-centre observational proof-of-concept diagnostic study, without blinded comparison, independent reference standard or treatment efficacy follow-up.

Reading depthMaterial consulted
Technical source record

Full local PDF read; All 13 PDF pages; Methods and statistics; Tables 1–2; Figures1–5 and captions; Discussion limitations; conclusions; declarations; references

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Study design

Single-centre observational proof-of-concept diagnostic study, without blinded comparison, independent reference standard or treatment efficacy follow-up.

Participants and setting

Twenty-eight adults with chronic nonspecific low-back pain were recruited by newspaper advertisement: 15 women, 13 men, mean age 59.0 years and mean symptom duration 87.39 months. Investigators selected 115 trigger-point/muscle observations; these are not 115 independent patients.

Treatment protocol

Wolf PiezoWave2 FB10 G10 focused source, approximately 10-mm focal zone, 5 Hz and 0.06–0.30 mJ/mm² adjusted to verbal tolerance. Gel spacers placed the focus 3–5 cm deep for lumbar/gluteal targets or 1–3 cm for superficial targets. Total pulses per diagnostic point were not reported.

Comparison

All tested sites were preselected using manual palpation by experienced clinicians. There was no randomized sham, asymptomatic control or blinded independent diagnostic reference.

What was measured

Patients answered yes/no about referred pain and recognition of their familiar pain during stimulation. Bilateral sites could be recorded separately. Table 2 labels counts as patients, while Methods describe positive registrations per stimulated trigger point; this unit ambiguity is retained.

Results and interpretation

Referral occurred in 25/26 quadratus-lumborum, 22/23 gluteus-medius and 13/14 gluteus-minimus selections; recognition in 22/26, 20/23 and 12/14. Iliopsoas referral was 13/14 but recognition only 7/14. One of 28 participants had neither response. These are elicitation proportions, not sensitivity, specificity or validated diagnostic accuracy.

Harms and disclosures

Pain was intentionally elicited and intensity adjusted to tolerance. No systematic adverse-event counts are provided. No external funding or conflicts were declared.

Limitations

The authors acknowledge one centre/investigator and palpation preselection. Small selected sample, subjective responses, no blinding or reference standard, repeated sites within participants and ambiguous units prevent claims of diagnostic accuracy or reproducibility. The reported recruitment end date is 31 September 2022, an invalid calendar date.

Applicability

The technique may help describe familiar pain in selected chronic low-back-pain patients. It has not been shown to distinguish radiculopathy, determine surgical indications, prevent failed surgery or improve treatment outcomes.

What stronger evidence needs

Use independent blinded examiners, repeatability testing, prespecified reference diagnoses, asymptomatic and disease controls, patient-level clustered analyses and prospective diagnostic accuracy/management outcomes.

THE ORIGINAL SOURCE

Read the original article.

The Use and Benefits of Focused Shockwaves for the Diagnosis of Myofascial Pain Syndrome by Examining Myofascial Trigger Points in Low Back Pain.

Müller-Ehrenberg H, Giordani F, Müller-Ehrenberg A, Stange R. · Biomedicines · 2024

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →